We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.62%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$178M
AUM Growth
+$108M
(+155%)
Cap. Flow
+$107M
Cap. Flow
% of AUM
60.42%
Top 10 Holdings %
Top 10 Hldgs %
3.93%
Holding
829
New
562
Increased
57
Reduced
34
Closed
175
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sprouts Farmers Market
SFM
|
+$969K |
| 2 |
TIGR
UP Fintech Holding
TIGR
|
+$737K |
| 3 |
Corporacion America
CAAP
|
+$729K |
| 4 |
LX
LexinFintech Holdings
LX
|
+$728K |
| 5 |
Wayfair
W
|
+$720K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cirrus Logic
CRUS
|
+$563K |
| 2 |
Monster Beverage
MNST
|
+$526K |
| 3 |
Clorox
CLX
|
+$510K |
| 4 |
Okta
OKTA
|
+$488K |
| 5 |
Nordson
NDSN
|
+$480K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.42% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 13.71% |
| 4 | Consumer Discretionary | 13.67% |
| 5 | Industrials | 13.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
QuinStreet
QNST
$893M
| $265K | 0.15% |
17,110
+4,925
| +40% | +$78.2K |
|
302
Klaviyo
KVYO
$5.31B
| $263K | 0.15% |
+9,516
| New | +$307K |
|
|
MRSH
303
Marsh
MRSH
$87.5B
| $263K | 0.15% |
+1,307
| New | +$269K |
|
304
Polaris
PII
$4.25B
| $263K | 0.15% |
+4,521
| New | +$244K |
|
|
DGNX
305
Diginex Ltd
DGNX
$43.9M
| $262K | 0.15% |
+2,274
| New | +$152K |
|
306
Kiniksa Pharmaceuticals
KNSA
$4.89B
| $261K | 0.15% |
+6,722
| New | +$218K |
|
307
Acuity Brands
AYI
$10.1B
| $261K | 0.15% |
+757
| New | +$241K |
|
308
East-West Bancorp
EWBC
$17.8B
| $261K | 0.15% |
+2,449
| New | +$258K |
|
309
Aquestive Therapeutics
AQST
$468M
| $260K | 0.15% |
+46,450
| New | +$201K |
|
310
Remitly
RELY
$4.77B
| $259K | 0.15% |
+15,870
| New | +$285K |
|
311
Pilgrim's Pride
PPC
$6.94B
| $259K | 0.15% |
+6,351
| New | +$288K |
|
312
Accel Entertainment
ACEL
$1.01B
| $259K | 0.15% |
+23,358
| New | +$273K |
|
313
Consolidated Water Co
CWCO
$472M
| $258K | 0.15% |
+7,326
| New | +$233K |
|
314
PTC
PTC
$14.5B
| $258K | 0.15% |
+1,273
| New | +$260K |
|
315
Amazon
AMZN
$2.49T
| $258K | 0.15% |
1,176
+10
| +0.9% | +$2.26K |
|
316
Tractor Supply
TSCO
$16.7B
| $257K | 0.14% |
+4,521
| New | +$266K |
|
317
iRadimed
IRMD
$1.22B
| $257K | 0.14% |
+3,608
| New | +$240K |
|
318
Independent Bank Corp
IBCP
$774M
| $256K | 0.14% |
+8,268
| New | +$267K |
|
319
Orrstown Financial Services
ORRF
$836M
| $255K | 0.14% |
+7,516
| New | +$255K |
|
320
TAL Education Group
TAL
$5.86B
| $255K | 0.14% |
+22,779
| New | +$245K |
|
321
Synchrony
SYF
$24.5B
| $255K | 0.14% |
+3,585
| New | +$260K |
|
322
Regions Financial
RF
$26.2B
| $254K | 0.14% |
+9,649
| New | +$251K |
|
323
Construction Partners
ROAD
$5.94B
| $253K | 0.14% |
+1,991
| New | +$227K |
|
324
Braze
BRZE
$2.65B
| $252K | 0.14% |
+8,864
| New | +$251K |
|
325
Williams Companies
WMB
$86.6B
| $252K | 0.14% |
+3,977
| New | +$233K |
|
Similar funds
BS
RG
MP
AIA
CCM
DFA
CCP
FRT
PharVision Advisers's Q3 2025 Portfolio in Review
As of Q3 2025, PharVision Advisers held 829 positions worth $178M, up 155% from $69.6M the previous quarter. Its ten largest holdings account for 3.9% of the portfolio.
PharVision Advisers deployed $107M of net new capital in Q3 2025, opening 562 new positions and adding to 57 existing holdings. Its largest new stake was Sprouts Farmers Market: 6,658 shares worth $724K.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Western Union, an estimated $321K trimmed.
- PharVision Advisers's largest Q3 2025 buy was Sprouts Farmers Market: 6,658 shares worth $724K.
- PharVision Advisers added most to Gogo Inc in Q3 2025, an estimated $397K increase.
- PharVision Advisers's biggest Q3 2025 reduction was Western Union, cutting an estimated $321K.
- PharVision Advisers fully exited Cirrus Logic in Q3 2025, selling an estimated $563K.
- PharVision Advisers's ten largest holdings make up 3.9% of its $178M portfolio in Q3 2025.
- PharVision Advisers opened 562 new positions and closed 175 in Q3 2025.
- PharVision Advisers's portfolio value rose 155% quarter-over-quarter to $178M.
Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.